2023 Global Vaping Industry Most Pioneering Products & Technologies

Industry Insight by 2FIRSTS

Jan.31.2024

2023 Global Vaping Industry Most Pioneering Products & Technologies

2FIRSTS has selected the "2023 Global Vape Industry Most Pioneering Products and Technologies," outlining the development trajectory of product evolution, hoping to inspire readers and collectively promote continuous positive innovation.

Special Statement:
This article is for internal industry research and exchange purposes only and does not make any brand or product recommendations. Access is prohibited for minors.

Editor's Note:

The era of high growth in the global e-cigarette industry in 2023 has officially come to an end. Compliance requirements and market competition have given rise to a series of new products and technologies, propelling the market competition in the global e-cigarette industry to a new stage. 2FIRSTS has reviewed the products and technologies of 2023 and identified the profound impact and inspiration of some products on the industry, even leading the development direction of global e-cigarette products. Based on this, 2FIRSTS has selected the "2023 Global Vape Industry Most Pioneering Products and Technologies," outlining the development trajectory of product evolution, hoping to inspire readers and collectively promote continuous positive innovation in industry technology and products.

2023 Global Vaping Industry Most Pioneering Products & Technologies

Also Read:

[1] China's Tobacco Exports Surge in 2023, Showing Impressive Growth

[2] 2023 China E-cigarette Exports Surge to $11.08 billion Amid 21.55% Unit Price Decline

#Europe #North America #United States #Legislation #Asia #Open system e-cigarettes #United Kingdom #Market #China #Disposable e-cigarettes #Products #Regulation #Heated tobacco products #Germany #E-cigarette Industry #Product

We welcome news tips, article submissions, interview requests, or comments on this piece.

Please contact us at info@2firsts.com, or reach out to Alan Zhao, CEO of 2Firsts, on LinkedIn

Notice

1. This article is intended solely for professional research purposes related to industry, technology, and policy. Any references to brands or products are made purely for objective description and do not constitute any form of endorsement, recommendation, or promotion by 2Firsts.

2. The use of nicotine-containing products — including, but not limited to, cigarettes, e-cigarettes, nicotine pouchand heated tobacco products — carries significant health risks. Users are responsible for complying with all applicable laws and regulations in their respective jurisdictions.

3. This article is not intended to serve as the basis for any investment decisions or financial advice. 2Firsts assumes no direct or indirect liability for any inaccuracies or errors in the content.

4. Access to this article is strictly prohibited for individuals below the legal age in their jurisdiction.

Copyright

This article is either an original work created by 2Firsts or a reproduction from third-party sources with proper attribution. All copyrights and usage rights belong to 2Firsts or the original content provider. Unauthorized reproduction, distribution, or any other form of unauthorized use by any individual or organization is strictly prohibited. Violators will be held legally accountable.

For copyright-related inquiries, please contact: info@2firsts.com

AI Assistance Disclaimer

This article may have been enhanced using AI tools to improve translation and editorial efficiency. However, due to technical limitations, inaccuracies may occur. Readers are encouraged to refer to the cited sources for the most accurate information.

We welcome any corrections or feedback. Please contact us at: info@2firsts.com

U.S. FDA Includes Cytisinicline for Vaping Addiction in National Priority Voucher Program, Shortens Review to 1–2 Months

The U.S. Food and Drug Administration (FDA) has added Cytisinicline, a plant-based therapy developed by Achieve Life Sciences for nicotine vaping addiction, to its new National Priority Voucher (CNPV) program. The initiative shortens drug review timelines from 10–12 months to just 1–2 months, expediting approval for treatments that address major public health needs.

Oct.20 by 2FIRSTS.ai

New Poll Shows 80% of Voters Support Strengthening Enforcement Against Illegal E-Cigarettes, Could Impact Swing Districts

A new poll shows 80% of voters support stronger enforcement against illegal e-cigarette production, potentially impacting swing districts.

Oct.17 by 2FIRSTS.ai

£600,000 of Illegal Goods Seized in West Yorkshire Raids Targeting Vape and Tobacco Laundering

Nearly £600,000 worth of illegal goods were seized in coordinated raids across West Yorkshire as part of Operation Machinize, a nationwide crackdown targeting cash-intensive businesses suspected of laundering money through mini-markets, vape shops, and barbershops.

Nov.12 by 2FIRSTS.ai

Feature | Vape Politics in Russia: Local Governments Push Forward Despite Legislative Deadlock

As Russia’s federal vape policy stalls, regional governors are racing to implement local bans—now with the backing of President Vladimir Putin. The divide between swift local action and delayed national legislation is fueling debate over health, regulation, and the country’s broader approach to nicotine control.